Home Applications 089007 Application 089007
Type ANDA
Sponsor MAYNE PHARMA INC Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 BUTALBITAL, ACETAMINOPHEN AND CAFFEINE ACETAMINOPHEN; BUTALBITAL; CAFFEINE CAPSULE;ORAL 325MG;50MG;40MG No Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A089007-001 BUTALBITAL, ACETAMINOPHEN AND CAFFEINE ACETAMINOPHEN; BUTALBITAL; CAFFEINE 325MG;50MG;40MG CAPSULE / ORAL AA RS 1986-03-17
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A089007-001 AA
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 44 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-10-28 04:53 UTC 2022-10 A089007-001 BUTALBITAL, ACETAMINOPHEN AND CAFFEINE 325MG;50MG;40MG CAPSULE / ORAL AA RS 1986-03-17 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A089007-001 BUTALBITAL, ACETAMINOPHEN AND CAFFEINE 325MG;50MG;40MG CAPSULE / ORAL AA RS 1986-03-17 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A089007-001 BUTALBITAL, ACETAMINOPHEN AND CAFFEINE 325MG;50MG;40MG CAPSULE / ORAL AA RS 1986-03-17 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A089007-001 BUTALBITAL, ACETAMINOPHEN AND CAFFEINE 325MG;50MG;40MG CAPSULE / ORAL AA RS 1986-03-17 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 44 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 9 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 51862-179 butalbital, acetaminophen and caffeine butalbital, acetaminophen and caffeine Mayne Pharma ANDA Current 51862-179 butalbital, acetaminophen and caffeine butalbital, acetaminophen and caffeine Mayne Pharma ANDA Current 51862-179 butalbital, acetaminophen and caffeine butalbital, acetaminophen and caffeine Mayne Pharma ANDA Current 68308-219 Esgic butalbital, acetaminophen and caffeine Mayne Pharma Inc. ANDA Current 68308-219 Esgic butalbital, acetaminophen and caffeine Mayne Pharma Inc. ANDA Current 68308-219 Esgic butalbital, acetaminophen and caffeine Mayne Pharma Inc. ANDA Current 68308-554 Zebutal butalbital, acetaminophen and caffeine Mayne Pharma Inc. ANDA Current 68308-554 Zebutal butalbital, acetaminophen and caffeine Mayne Pharma Inc. ANDA Current 68308-554 Zebutal butalbital, acetaminophen and caffeine Mayne Pharma Inc. ANDA Current